Overview of Autoimmune Disease Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Overview of Autoimmune Diseases

A
  • affect 5% of the population- incidence is increased in women and in developed countries
  • self antigen is recognized as foreign as foreign by immune system and there is a failure of regulatory mechanisms
  • effector mechanisms include types II, III, IV hypersensitivity reactions
  • may be organ-specific, affecting only a few select cells or organs or systemic, affecting multiple organs
  • most autoimmune diseases have no known cause or cure and treatment is aimed at controlling symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Factors contributing to development of autoimmune diseases

A
  • immune factors- all autoimmune diseases involve the breakdown of T and B cell tolerance and the production of autoantibody and/or inflammatory autoreactive T cells
  • genetic factors- there is a genetic predisposition to develop autoimmune diseases
  • environmental factors modulate and/or trigger autoimmune diseases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do contributing factors develop to autoimmune disease

A
  • trigger (infection?) seems to be required- bacterial products required to induce autoimmune response to injected self proteins
  • also increases in disease incidence supports a role for environmental factors
  • susceptibility genes -> failure of self tolerance -> influx of self-reactive lymphocytes into tissues
  • tissue injury: autoimmune disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Breakdown in B cell tolerance

A
  • central B cell tolerance- clonal deletion of self-reactive B cells in the bone marrow (but not all are deleted)
  • peripheral B cell tolerance- without cognate T cell help, antigen-activated B cells in the T cell zone of a lymph node die by apoptosis
  • B cells may also become anergic after encounter with soluble antigen, and then will be eliminated by antigen-specific T cell through Fas signaling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Breakdown in T cell tolerance

A
  • normally T cells that bind to self peptides presented by MHC on the thymic cells are deleted
  • defects in AIRE leads to the production of a variety of autoimmune B and T cell responses and autoimmune polyglandular disease
  • even if negative selection works properly, some autoreactive cells do escape- controlled by peripheral tolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Insufficient control of T-cell costimulation

A
  • activation of naive T cells require both antigen presentation and costimulation (B-7/CD28) -> most cells producing tissue-specific antigens do not express costimulatory molecules
  • autoreactive T cells may lower threshold for activation
  • allelic variants of CTLA-4 (soluble and membrane CTLA-4 compete for binding to B-7
  • CD40, CD40L varients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lack of Regulatory T cells (Treg) may contribute to autoimmune disease

A
  • CD4+, CD25+, CTLA-4+ producing IL-4, IL-10, and TGFB (TH2)
  • require cell contact and CTLA-4 for activity
  • suppression of autoreactive T cells by regulatory T cells requires them to interact with the same antigen-presenting cell
  • defects in FoxP3, a transcription repressor gene uniqueto Treg results in autoimmune disease, mainly in bodys
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Inflammatory Th17 cells in autoimmune disease

A
  • helper CD4+ T cells that secrete IL-17
  • pro-inflammatory binds to IL-17 receptor on fibroblasts epithelial cells and keratinocytes, leading to secretion of cytokines and recruitment of inflammatory cells
  • may accumulate in affected tissues in Crohn’s diseae, RA, psoriasis, allergic asthma
  • link between infection and autoimmunity?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Genetic factor affecting autoimmune disease

A
  • genes located in the MHC region
  • different combinations of HLA II allotypes confer susceptibility and resistance to some autoimmune diseases
  • variants of complement (complotypes)
  • variants of CTLA-4
  • variants of AIRE
  • variants of Fas and Fas L
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Other Factors- Release of sequestered antigens

A
  • trauma to sites of immune privilege- normally entry of naive lymphocytes is prevented but self antigens may be exposed to circulation by wound or infection, and effector cells can gain access
  • sympthetic ophthalmia
  • also UV damage to skin in lupus, chemicals in cigarette smoke damage lung alveoli, brain trauma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Self proteins may be modified to appear foreign

A
  • celiac disease
  • gluten is degraded in the gut lumen to give a resistant fragment
  • gluten fragment enters gut tissue and is deaminated by transglutaminase
  • naive CD4 T cell responds to deaminated peptides presented by HLA-DQ
  • inflammatory effector T cells cause villous atrophy
  • result-> diarrhea, malabsorption of nutrients
  • IgG or IgA antibodies to tissue transglutaminase may also be produced
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Associations of infection with autoimmunity

A
  • Group A Strep- rheumatic fever
  • Chlamydia teachomatis- HLA-B27- Reiter’s syndrome
  • Shigella, Salmonella, Yersinia, Campylobacter jejuni, HLA-B27, reactive arthritis
  • Borrelia Burgdorferi- HLA-DR2, DR4- chronic arthrtis in lyme disease-
  • Coxsackies and rubella- Type I diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Molecular mimicry

A
  • pathogen-derived peptides structurally similar to a self-antigen stimulate a TH1 cell response directed against the self-antigen
  • other possible mechanism(s) include infection of APC, inflammatory tissue damage leading to bystander effect, polyclonal activation of autoreactive cells (superantigen, LPS), creation of neoantigens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

infection may also lead to increased antigen presentation

A
  • during infection class I and class II expression may be induced or increased due to interferon gamma production
  • Hashimoto’s disease- thyroid gland resembles secondary lymphoid tissue, with B and T cells present
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Additional factors may contribute to disease mechanisms in genetically susceptible individuals

A
  • chemicals (pesticides, solvents, industrial pollutants, drugs)
  • metals (mercury, lead)
  • hormones (estrogen, phytoestrogens)- 90% of all autoimmune diseases occur in women
  • stress
  • diet
  • age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Antibody-mediated autoimmune diseases

A
  • a single type of cell (organ) is targeted by autoantibodies, thus this type of autoimmune disease is organ-specific. The effector mechanisms correspond to Type II hypersensitivity reactions
  • Autoimmune hemolytic anemia- destruction of RBCs
  • Autoimmune thrombocytopenia-abnormal bleeding
  • Goodpasture’s syndrome-glomerulonephritis
  • Grave’s Disease- hyperthyroidism
  • Myasthenia gravis- antibodies to AChR
  • Insulin-resistant diabetes
  • Hashimotos’ disease- hypothryoidism
17
Q

Hemolytic Anemia

A

-IgG autoantibodies bound to Rh or I antigens may promote antibody-dependent cell-mediated cytotoxicity (ADCC) or complement fixation

18
Q

Graves’ disease

A
  • normally, thyroid-stimulating hormone (TSH) induces the breakdown of iodinated thyroglobulin, releasing T3 and T4 signaling the pituitary to stop releasing TSH
  • in Graves’ disease autoantibodies bind to the TSH receptor of thyroid cells, mimicking the action of TSH so more thyroid hormones are released
  • incidence 1 in 100
19
Q

Myasthenia gravis

A
  • acetylcholine binds to Ach receptors on muscle cells, causing an inflow of sodium ions that indirectly causes muscle contraction (left)
  • in Myasthenia gravis, anti-acetylchloline receptor Ig binds to the receptors lead to decreased sensitivity to stimulation, and progressive muscle weakening
20
Q

IgG-mediated diseases may be transfered in utero

A
  • mother with Graves’ disease makes anti-TSHR antibodies
  • during pregnancy, antibodies cross the placenta into the fetus
  • newborn infant also suffers from Graves’ disease
  • plasmapheresis removed maternal anti-TSHR antibodies and cures the infant’s disease
  • other examples: Hemolytic disease of the newborn, Myasthenia gravis, Thrombocytopenia purpura, Neonatal lupus
  • lymphocytes cannot pass from mother to fetus so babies born to mothers with T cell mediated autoimmune diseases do not show disease symptoms
21
Q

Immune complex-mediated autoimmune disease

A
  • type II hypersensitivity effector mechanisms
  • directed at multiple cells of the body, resulting in a systemic autoimmune response
  • fix in tissues, fix complement, leading to the influx of inflammatory cells, resulting in tissue damage
22
Q

Systemic Lupus Erythematous (SLE)

A
  • chronic systemic autoimune disease, with flares and remissions
  • immune complexes contain anti-DNA, anti-nucleosome antibodies, among others
  • anti-dsDNA titer is diagnostic
  • specificity of response broadens over time- epitope spreading
  • incidence is about 1 in 200 with more women than men affected; also more prevalent in females of African and Asian dscent
  • symptoms may include butterfly-shaped rash on face, fatigue, headaches among others
23
Q

T cell-mediated autoimmune disease

A
  • Type IV hypersensitivity effector mechanisms (DTH)
  • antigen-specific T cells activated by antigen, as well as other immune cells (macrophages, mast cells) lead to inflammatory response
  • insulin-dependent diabetes mellitus
  • rheumatoid arthritis
  • multiple sclerosis
  • systemic lupus erythematosus
24
Q

Juvenile diabetes

A
  • incidence 1 in 800with diagnosis usually before age 30
  • also known as type I diabetes or insulin dependent diabetes
  • beta cells in the pancreas produce little or no insulin due to destruction by inflammatory cytotoxic CD8+ T cells
  • symptoms include increase thirst and urination, weight loss, nausea, fatigue
25
Q

Rheumatoid arthritis

A
  • incidence is about 1 in 100 with onset most often between the ages of 25-55; women 4 times more likely to develop
  • caused by the production of antibodies that react with constant regions of other antibodies (rheumatoid factor) and infiltration of the joint synvium by inflammatory CD4+ and CD8+ T cells
  • classified variably as immune complex-mediated or T cell mediated
  • secretion of TNFalpha, IL-1, IL-6, IL-7 leads to recruitment of effector cells
  • symptoms include weakness, fatigue and joint pain
26
Q

Multiple Sclerosis

A
  • chronic organ-specific disease- may be mild or severe
  • affects 1 in 700 people, 60% of the cases occur in women
  • inflammation of brain leads to permeability of blood brain barrier
  • myelin sheath covering cells of spinal cord and brain destroyed due to TH1 CD4+ T cells which secrete IFNgamma and activation
  • autoantibodies to myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein
  • symptoms may disappear and recur over time and include weakness, tremors or paralysis of one or more extremities, numbness, decreased memory and attention span
27
Q

Treatment for autoimmune diseases

A
  • physical removal of antigen, antibody or immune complexes-splenectomy
  • IV Ig
  • anti-inflammatories
  • depletion of immune cells
  • blocking interaction and/or activation of immune cells, bind cytokines or block second signals
  • replacement therapy-insulin
  • hormones, diet, exercise